Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis.

Schoof L, Heijnen R, Hogenboom L, Van Kempen Z L E, de Jong B A, van Oosten BW, Killestein J, Barkhof F, Strijbis EM

Neurology. 2026 Aug 25; 107(4):e218379. PMID: 42525900. Abstract